Qualigen Therapeutics Q2 EPS $(0.69) Up From $(1.10) YoY, Sales $1.63M Up From $1.43M YoY
Portfolio Pulse from Happy Mohamed
Qualigen Therapeutics reported Q2 losses of $(0.69) per share, a 37.27% improvement from $(1.10) per share YoY. Sales also increased by 13.70% to $1.63M from $1.43M YoY.
August 15, 2023 | 12:52 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Qualigen Therapeutics reported improved Q2 results with reduced losses and increased sales YoY.
Qualigen Therapeutics reported a significant improvement in their Q2 results with a reduction in losses and an increase in sales compared to the same period last year. This positive financial performance could potentially lead to a short-term increase in the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100